What type of study is this?

This is a Quantitative Study study.

October 19, 2025International Journal of Molecular SciencesOpen Access

Plasma with Added Protease Inhibitors Improves Alpha- and Beta-CGRP Measurement Compared to Serum: Towards a Reliable Biomarker for Chronic Migraine

View Full Paper

Ask AI

Bookmark

Authors

LGLucía de la Guerra-Sasián GGGabriel GárateUniversidad de Cantabria JMJorge MaderaUniversidad de Cantabria

Discussion

Member takes

Implication

This analysis demonstrates enhanced α-CGRP detection in plasma samples with protease inhibitors, suggesting better measurement reliability for chronic migraine.

Key Points

Increased α-CGRP detection was noted when protease inhibitors were added to plasma samples, indicating a significant methodological advancement.
Statistical assessments revealed that α-CGRP levels decreased during treatment, while β-CGRP levels exhibited stability, underscoring differing dynamics of these markers.
No significant correlation between the α-CGRP and β-CGRP levels in plasma was observed, suggesting independent regulation of the two neuropeptide isoforms.
The study highlights the potential for α-CGRP as a reliable biomarker for chronic migraine, impacted by age and treatment.

Cite This Study

Guerra-Sasián et al. (2025) studied this question.

synapsesocial.com/papers/68f43ef4854d1061a58abd19 https://doi.org/10.3390/ijms26209958

View Full Paper

Ask AI

Bookmark

October 19, 2025International Journal of Molecular SciencesOpen Access

Plasma with Added Protease Inhibitors Improves Alpha- and Beta-CGRP Measurement Compared to Serum: Towards a Reliable Biomarker for Chronic Migraine

View Full Paper

Ask AI

Bookmark

Authors

LGLucía de la Guerra-Sasián GGGabriel GárateUniversidad de Cantabria JMJorge MaderaUniversidad de Cantabria

Discussion

Member takes

Implication

This analysis demonstrates enhanced α-CGRP detection in plasma samples with protease inhibitors, suggesting better measurement reliability for chronic migraine.

Key Points

Increased α-CGRP detection was noted when protease inhibitors were added to plasma samples, indicating a significant methodological advancement.
Statistical assessments revealed that α-CGRP levels decreased during treatment, while β-CGRP levels exhibited stability, underscoring differing dynamics of these markers.
No significant correlation between the α-CGRP and β-CGRP levels in plasma was observed, suggesting independent regulation of the two neuropeptide isoforms.
The study highlights the potential for α-CGRP as a reliable biomarker for chronic migraine, impacted by age and treatment.

Cite This Study

Guerra-Sasián et al. (2025) studied this question.

synapsesocial.com/papers/68f43ef4854d1061a58abd19 https://doi.org/10.3390/ijms26209958

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark